Johns Hopkins, baltimore, MD. RATIONALE: Components-complement cascade participates in Th2-biased immunity in asthma. We have discovered that miRNA-511-3p targets complement component 3 (C3), a central mediator of componentscomplement activation. We hypothesized that C3 plays a role in allergeninduced allergic inflammation. METHODS: Targeted delivery of miR-511-3p to the mouse respiratory tract was used to determine the role of complement activation in asthma. miRNA-511-3p-C3 interaction was examined in vitro and in silico. miR-511-3p regulation of C3 mRNA was also assessed in bone marrow-derived macrophages. RESULTS: miR-511-3p delivery by adeno-associated virus (AAV-9) vector to the mouse respiratory tract decreased lung C3 mRNA levels and is associated with decreased inflammatory cells recruitment, dense peribronchial infiltrates, and goblet hyperplasia compared to mock controls in our cockroach allergen (CRE)-induced mouse model of asthma. Furthermore, serum and BALF analysis showed decreased levels of CRE-specific immunoglobulins (IgG1 and IgE) and Th2 cytokines (IL4 and IL13). C3 could be antagonized by miRNA-511-3p, which was confirmed in bone in bone marrow-derived macrophages using miRNA mimics. In silico analysis also demonstrated that miR-511-3p can bind to C3 mRNA with relatively high affinity. CONCLUSIONS: Collectively, we demonstrated a role for C3 in the elicitation of a Th2-biased immunity in asthma, which can be targeted by miR-511-3p. Our findings will lay the groundwork to target componentscomplement activation as a therapeutic target for allergic inflammation and asthma. National Jewish Health/University of Colorado Denver, Denver, CO, 5 National Jewish Health and University of Colorado, Denver, CO. RATIONALE: ILCs do not express antigen-specific receptors. Whether they are capable of generating memory for allergens is unknown. METHODS: Mouse model of asthma, single cell RNA-seq and flow cytometry RESULTS: Exposure of Rag1 KO mice intranasally to PAMP-containing (Alternaria, dust mite, papain) allergens 3 days/week for 3 weeks generated a form of memory, which elicited an asthma-like response (airway hyperreactivity, eosinophilic inflammation and IL5+IL13+ ILC2s in the lung) upon a recall challenge with a subthreshold dose of the allergen 3-9 weeks later. This memory was PAMP-dependent and PAMP-specific. Ovalbumin, which lacks a PAMP, was ineffective. Alternaria-induced memory was recalled by Aspergillus (both contain the PAMP serine protease) but not dust mite (contains cysteine protease) challenge. Conversely, papain (a cysteine protease)-induced memory could be recalled by dust mite challenge. Sensitization with Alternaria that was pretreated with the serine protease inhibitor AEBSF abrogated memoryinduced asthma implicating a role for serine protease-PAR2 interaction. Antibody-mediated elimination of NK cells did not affect memory-driven asthma suggesting a primary role for ILCs. Single cell RNA-seq identified 297 differentially expressed genes in the memory model. We validated upregulation of select genes including ICOS, CD90 and FHL2 by flow cytometry. Adoptive transfer of Alternaria-sensitized mouse lung ICOS+ ILC2s and human lung FHL2+ ILC2s to Rag2-/-:gc-/-mice induced asthma upon Alternaria challenge. Genetic and antibody-mediated depletion of ICOS inhibited memory-driven asthma. Likewise, antibodymediated depletion of CD90 abrogated asthma. CONCLUSIONS: ILCs generate memory for allergen-associated PAMPs, which is associated with upregulation of select genes. Interference with these memory-associated ILC expressed genes may benefit asthma.
